Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono, +21

New England Journal of Medicine

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

Heikki Joensuu, Petri Bono, Vesa Kataja, +17

Journal of Clinical Oncology

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

Pirkko‐Liisa Kellokumpu‐Lehtinen, Ulrika Harmenberg, Timo Joensuu, +17

The Lancet Oncology

UrologyOncologyGenitourinary CancerClinical TrialsPharmacotherapy +3

Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, +17

Journal of Clinical Oncology

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, +21

The Lancet Oncology

Breast OncologyOncologyMedicineAdjuvant CapecitabineClinical Trials +5

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

R. Asola, Heini Huhtala, K Holli

Breast Cancer Research and Treatment

NursingPalliative CareAdvanced Breast CancerBreast OncologyTreatment Activities +7

Delayed diagnosis and large size of breast cancer after a false negative mammogram

Heikki Joensuu, R. Asola, K Holli, +3

European Journal of Cancer

Surgical OncologyBreast OncologyCancer DetectionMedicineLarge Size +7

Weekly paclitaxel--an effective treatment for advanced breast cancer.

Pirkko Kellokumpu‐Lehtinen, Tuija Tuunanen, R. Asola, +10

PubMed

A flow cytometric analysis of 23 carcinoid tumors

Harry Kujari, Heikki Joensuu, Pekka Klemi, +2

Cancer

Flow Cytometric AnalysisUrologyTumoral PathologyGenitourinary CancerTumor Heterogeneity +8

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

Heikki Joensuu, Liisa Sailas, Tuomo Alanko, +12

Annals of Oncology

Advanced Breast CancerBreast OncologyMedicineRandomised TrialPharmacology +6